Article Versions Notes

Furuse J, Izumi N, Motomura K, Inaba Y, Katamura Y, Kondo Y, Yabushita K, Matsuoka T, Motoyoshi K, Kudo M. Long-Term Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in Real-World Clinical Practice. Cancers. 2025; 17(3):479. https://doi.org/10.3390/cancers17030479

Furuse, Junji, Namiki Izumi, Kenta Motomura, Yoshitaka Inaba, Yoshio Katamura, Yasuteru Kondo, Kazuhisa Yabushita, Toshiyuki Matsuoka, Katsuaki Motoyoshi, and Masatoshi Kudo. 2025. "Long-Term Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in Real-World Clinical Practice" Cancers 17, no. 3: 479. https://doi.org/10.3390/cancers17030479

Furuse, J., Izumi, N., Motomura, K., Inaba, Y., Katamura, Y., Kondo, Y., Yabushita, K., Matsuoka, T., Motoyoshi, K., & Kudo, M. (2025). Long-Term Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in Real-World Clinical Practice. Cancers, 17(3), 479. https://doi.org/10.3390/cancers17030479